Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
JOURNALS
PSYCHOPHARMACOLOGY BULLETIN
FULL ISSUE STACKED PDFs
T.E.N.
MENTAL FITNESS
PSI
ONCOLOGY SPECTRUMS
PROJECTS
JOURNAL SUPPLEMENTS
PHYSICIAN ACADEMY SERIES
POCKET REFERENCE GUIDES
TEACHING MONOGRAPHS
MEDWORKS REPRINT SERIES
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOTROPIC PRESCRIBING INFORMATION
PSYCHOTROPIC DOSAGE RANGES
PSYCHOPHARMACOLOGY 101
PSYCHIATRIC RATING SCALES
NEWS
WE KNOW PSYCHIATRY
FEATURED ARTICLES
Home
Eduard Parellada, MD, MSc, PhD: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations
Eduard Parellada, MD, MSc, PhD: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations
$
30.00
Eduard Parellada, MD, MSc, PhD: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 40 No. 2 Articles
Tags:
eduard-parellada
,
ethnicityrace
,
health-disparities
,
illness-characteristics
,
ipolar-disorder
,
md
,
msc
,
phd
Description
Description
Eduard Parellada, MD, MSc, PhD
DRUG DISPOSITION & PHARMACOKINETICS
Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations
Eduard Parellada, MD, MSc, PhD
Related products
Strategies for Treatment-Resistant Depression
$
30.00
Add to cart
Details
P. Murali Doraiswamy, MD: Donepezil for Cognitive Decline Following Coronary Artery Bypass Surgery: A Pilot Randomized Controlled Trial
$
30.00
Add to cart
Details
New Goals in the Treatment of Depression: Moving Toward Recovery By Michael E. Thase, MD, and Philip T. Ninan, MD
$
30.00
Add to cart
Details
Ethical Issues In Schizophrenia: Considerations for Treatment and Research
$
0.00
Add to cart
Details
Page load link
Go to Top
